197 related articles for article (PubMed ID: 33793038)
1. Risk of cancer in long-term levothyroxine users: Retrospective population-based study.
Wu CC; Islam MM; Nguyen PA; Poly TN; Wang CH; Iqbal U; Li YJ; Yang HC
Cancer Sci; 2021 Jun; 112(6):2533-2541. PubMed ID: 33793038
[TBL] [Abstract][Full Text] [Related]
2. Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study.
Wu CC; Yu YY; Yang HC; Nguyen PA; Poly TN; Islam MM; Iqbal U; Khan HAA; Wang YC; Cheng YT; Li YC; Jian WS
Arch Gynecol Obstet; 2018 Aug; 298(2):389-396. PubMed ID: 29961136
[TBL] [Abstract][Full Text] [Related]
3. Levothyroxine treatment and occurrence of fracture of the hip.
Sheppard MC; Holder R; Franklyn JA
Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
[TBL] [Abstract][Full Text] [Related]
4. Thyroxin Use Is Associated With Increased Risk of Thyroid Cancer in Patients With Hypothyroidism.
Hung SH; Chung SD; Lin HC
J Clin Pharmacol; 2018 Jan; 58(1):29-33. PubMed ID: 28724195
[TBL] [Abstract][Full Text] [Related]
5. Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.
Lin SY; Lin CL; Chen HT; Kao CH
Curr Med Res Opin; 2018 May; 34(5):805-812. PubMed ID: 28884595
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism and the increased risk of preeclampsia - interpretative factors?
Lintula A; Keski-Nisula L; Sahlman H
Hypertens Pregnancy; 2020 Nov; 39(4):411-417. PubMed ID: 32787605
[TBL] [Abstract][Full Text] [Related]
7. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN; Iqbal A; Minassian C; Sayers A; Draman MS; Greenwood R; Hamilton W; Okosieme O; Panicker V; Thomas SL; Dayan C
JAMA Intern Med; 2014 Jan; 174(1):32-9. PubMed ID: 24100714
[TBL] [Abstract][Full Text] [Related]
8. Levothyroxine dose and risk of fractures in older adults: nested case-control study.
Turner MR; Camacho X; Fischer HD; Austin PC; Anderson GM; Rochon PA; Lipscombe LL
BMJ; 2011 Apr; 342():d2238. PubMed ID: 21527461
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality.
Andersen MN; Olsen AM; Madsen JC; Faber J; Torp-Pedersen C; Gislason GH; Selmer C
PLoS One; 2015; 10(6):e0129793. PubMed ID: 26069971
[TBL] [Abstract][Full Text] [Related]
10. Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study.
Sohn SY; Seo GH; Chung JH
Front Endocrinol (Lausanne); 2021; 12():680647. PubMed ID: 34054737
[TBL] [Abstract][Full Text] [Related]
11. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.
Kim MS; Lee JW; Hyun MK; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):288-299. PubMed ID: 38437824
[TBL] [Abstract][Full Text] [Related]
12. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
13. Levothyroxine dose and risk of atrial fibrillation: A nested case-control study.
Gong IY; Atzema CL; Lega IC; Austin PC; Na Y; Rochon PA; Lipscombe LL
Am Heart J; 2021 Feb; 232():47-56. PubMed ID: 33022231
[TBL] [Abstract][Full Text] [Related]
14. Association between Sudden Sensorineural Hearing Loss and Preexisting Thyroid Diseases: A Nationwide Case-Control Study in Taiwan.
Tsai YT; Chang IJ; Hsu CM; Yang YH; Liu CY; Tsai MS; Chang GH; Lee YC; Huang EI; Lin MH; Luan CW
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32013113
[No Abstract] [Full Text] [Related]
15. Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart Disease.
Andersen MN; Olsen AS; Madsen JC; Kristensen SL; Faber J; Torp-Pedersen C; Gislason GH; Selmer C
J Clin Endocrinol Metab; 2016 Nov; 101(11):4170-4177. PubMed ID: 27571183
[TBL] [Abstract][Full Text] [Related]
16. Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis.
Hepp Z; Wyne K; Manthena SR; Wang S; Gossain V
Curr Med Res Opin; 2018 Sep; 34(9):1673-1678. PubMed ID: 29874941
[TBL] [Abstract][Full Text] [Related]
17. Does long-term use of antidiabetic drugs changes cancer risk?
Liu YC; Nguyen PA; Humayun A; Chien SC; Yang HC; Asdary RN; Syed-Abdul S; Hsu MH; Moldovan M; Yen Y; Li YJ; Jian WS; Iqbal U
Medicine (Baltimore); 2019 Oct; 98(40):e17461. PubMed ID: 31577776
[TBL] [Abstract][Full Text] [Related]
18. Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers - a cohort study of the Swedish population.
Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
Cancer Epidemiol; 2020 Jun; 66():101707. PubMed ID: 32222650
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
20. The emergence of levothyroxine as a treatment for hypothyroidism.
Hennessey JV
Endocrine; 2017 Jan; 55(1):6-18. PubMed ID: 27981511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
